LBR
Delta(14)-sterol reductase LBR
Also known as: DHCR14B, LBR_HUMAN, TDRD18
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14739
- Gene
- LBR
- Ensembl
- ENSG00000143815
- Chromosome
- 1
- Canonical length
- 615 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nuclear membrane,Nucleoli fibrillar center
OverviewNCBI Gene
The protein encoded by this gene belongs to the ERG4/ERG24 family. It localized in the nuclear envelope inner membrane and anchors the lamina and the heterochromatin to the membrane. It may mediate interaction between chromatin and lamin B. Mutations of this gene has been associated with autosomal recessive HEM/Greenberg skeletal dysplasia. Alternative splicing occurs at this locus and two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
615 residues, UniProt reviewed canonical sequence.
>Q14739|LBR
1 MPSRKFADGE VVRGRWPGSS LYYEVEILSH DSTSQLYTVK YKDGTELELK ENDIKPLTSF
61 RQRKGGSTSS SPSRRRGSRS RSRSRSPGRP PKSARRSASA SHQADIKEAR REVEVKLTPL
121 ILKPFGNSIS RYNGEPEHIE RNDAPHKNTQ EKFSLSQESS YIATQYSLRP RREEVKLKEI
181 DSKEEKYVAK ELAVRTFEVT PIRAKDLEFG GVPGVFLIMF GLPVFLFLLL LMCKQKDPSL
241 LNFPPPLPAL YELWETRVFG VYLLWFLIQV LFYLLPIGKV VEGTPLIDGR RLKYRLNGFY
301 AFILTSAVIG TSLFQGVEFH YVYSHFLQFA LAATVFCVVL SVYLYMRSLK APRNDLSPAS
361 SGNAVYDFFI GRELNPRIGT FDLKYFCELR PGLIGWVVIN LVMLLAEMKI QDRAVPSLAM
421 ILVNSFQLLY VVDALWNEEA LLTTMDIIHD GFGFMLAFGD LVWVPFIYSF QAFYLVSHPN
481 EVSWPMASLI IVLKLCGYVI FRGANSQKNA FRKNPSDPKL AHLKTIHTST GKNLLVSGWW
541 GFVRHPNYLG DLIMALAWSL PCGFNHILPY FYIIYFTMLL VHREARDEYH CKKKYGVAWE
601 KYCQRVPYRI FPYIYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LBR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- thymus: 98 nTPM
- bone marrow: 90 nTPM
- lymph node: 76 nTPM
- tonsil: 66 nTPM
- colon: 56 nTPM
- appendix: 50 nTPM
Single-cell type
- neutrophils: 853 nCPM
- neutrophil progenitors: 750 nCPM
- monocyte progenitors: 357 nCPM
- erythrocyte progenitors: 337 nCPM
- monocytes: 128 nCPM
- enteric transient amplifying cells: 118 nCPM
Immune cell
- neutrophil: 212 nTPM
- basophil: 84 nTPM
- total PBMC: 70 nTPM
- eosinophil: 67 nTPM
- T-reg: 62 nTPM
- naive CD8 T-cell: 53 nTPM
Brain region
- white matter: 19 nTPM
- medulla oblongata: 18 nTPM
- pons: 14 nTPM
- hypothalamus: 13 nTPM
- spinal cord: 13 nTPM
- midbrain: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LBR.
Disease | AllUniProt
Conditions LBR is implicated in, by any mechanism.
- Pelger-Huet anomaly (PHA) MIM:169400
- Greenberg dysplasia (GRBGD) MIM:215140
- Reynolds syndrome (REYNS) MIM:613471
- Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly (SKPHA) MIM:618019
Disease | GeneticClinVar
30 pathogenic / likely-pathogenic of 485 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Greenberg dysplasia
- Pelger-Huët anomaly
- RHIZOMELIC SKELETAL DYSPLASIA WITH PELGER-HUET ANOMALY
- Regressive spondylometaphyseal dysplasia
- LBR-related disorder
Disease | ImmuneIEDB
Conditions an epitope on LBR was assayed in.
- rheumatoid arthritis B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against LBR are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for LBR from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
1990 · J Exp Med · RCR 3.3 · 105 citations - Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.
1994 · Gastroenterology · RCR 3.1 · 89 citations - Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
1997 · Semin Liver Dis · RCR 1.9 · 78 citations - Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.
1996 · Hepatology · RCR 0.9 · 39 citations - Diagnostic autoantibodies for autoimmune liver diseases.
2017 · Clin Transl Immunology · RCR 0.8 · 21 citations
Show 2 more
- Human autoantibodies to lamin B receptor are also anti-idiotypic to certain anti-lamin B antibodies.
1991 · Eur J Immunol · RCR 0.7 · 18 citations - Anti-nuclear envelope antibodies: Clinical associations.
2001 · Semin Arthritis Rheum · RCR 0.7 · 26 citations
Reference: B cellIEDB
1 publication
- Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- chromatin-protein adaptor activity
- chromo shadow domain binding
- Delta14-sterol reductase activity
- DNA binding
- lamin binding
- NADPH binding
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sterol biosynthesis ERG24/DHCR-like
- Tudor domain
- Sterol reductase, conserved site
- Ergosterol biosynthesis ERG4/ERG24 family
- Lamin-B receptor of TUDOR domain
- Lamin-B receptor of TUDOR domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LBR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LBR as an antibody target. Whether an autoantibody or antibody against LBR could matter depends on whether native LBR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LBR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LBR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...